{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T21:40:07Z","timestamp":1727041207867},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,22]]},"DOI":"10.7759\/cureus.69937","type":"journal-article","created":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T21:07:14Z","timestamp":1727039234000},"source":"Crossref","is-referenced-by-count":0,"title":["Stereotactic Ablative Radiotherapy for Oligometastatic Pericolonic Soft Tissue Metastases Using Daily Cone-Beam Computed Tomography-Guided Online Adaptive Radiotherapy"],"prefix":"10.7759","author":[{"given":"Benjamin","family":"Mou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109576","article-title":"Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? A secondary analysis of the population-based phase II SABR-5 trial","volume":"182","author":"Eufemon Cereno R","year":"2023","unstructured":"Eufemon Cereno R, Mou B, Baker S, et al.. Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? A secondary analysis of the population-based phase II SABR-5 trial. Radiother Oncol. 2023, 182:109576. 10.1016\/j.radonc.2023.109576","journal-title":"Radiother Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.01.002","article-title":"Determining planning priorities for SABR for oligometastatic disease: a secondary analysis of the SABR-comet phase II randomized trial","volume":"114","author":"Van Oirschot M","year":"2022","unstructured":"Van Oirschot M, Bergman A, Verbakel WF, et al.. Determining planning priorities for SABR for oligometastatic disease: a secondary analysis of the SABR-comet phase II randomized trial. Int J Radiat Oncol Biol Phys. 2022, 114:1016-21. 10.1016\/j.ijrobp.2022.01.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2024.101500","article-title":"Radioresistant pulmonary oligometastatic and Oligoprogressive lesions from Nonlung primaries: impact of histology and dose-fractionation on local control after radiation therapy","volume":"9","author":"Verma N","year":"2024","unstructured":"Verma N, Laird JH, Moore NS, et al.. Radioresistant pulmonary oligometastatic and Oligoprogressive lesions from Nonlung primaries: impact of histology and dose-fractionation on local control after radiation therapy. Adv Radiat Oncol. 2024, 9:101500. 10.1016\/j.adro.2024.101500","journal-title":"Adv Radiat Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.10.021","article-title":"Adaptive radiation therapy (ART) strategies and technical considerations: a state of the art review from NRG Oncology","volume":"109","author":"Glide-Hurst CK","year":"2021","unstructured":"Glide-Hurst CK, Lee P, Yock AD, et al.. Adaptive radiation therapy (ART) strategies and technical considerations: a state of the art review from NRG Oncology. Int J Radiat Oncol Biol Phys. 2021, 109:1054-75. 10.1016\/j.ijrobp.2020.10.021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2023.101382","article-title":"Radiation therapy for colorectal liver metastasis: the effect of radiation therapy dose and chemotherapy on local control and survival","volume":"9","author":"Chen I","year":"2024","unstructured":"Chen I, Jeong J, Romesser PB, et al.. Radiation therapy for colorectal liver metastasis: the effect of radiation therapy dose and chemotherapy on local control and survival. Adv Radiat Oncol. 2024, 9:101382. 10.1016\/j.adro.2023.101382","journal-title":"Adv Radiat Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1533033818794936","article-title":"Radiation therapy for colorectal liver metastasis: the effect of radiation therapy dose and chemotherapy on local control and survival","volume":"17","author":"Jingu K","year":"2018","unstructured":"Jingu K, Matsushita H, Yamamoto T, et al.. Radiation therapy for colorectal liver metastasis: the effect of radiation therapy dose and chemotherapy on local control and survival. Technol Cancer Res Treat. 2018, 17:1533033818794936. 10.1177\/1533033818794936","journal-title":"Technol Cancer Res Treat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2022.08.008","article-title":"Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease","volume":"37","author":"Willmann J","year":"2022","unstructured":"Willmann J, Vlaskou Badra E, Adilovic S, et al.. Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease. Clin Transl Radiat Oncol. 2022, 37:12-8. 10.1016\/j.ctro.2022.08.008","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071713","article-title":"Health-related quality of life in metastatic colorectal cancer patients treated with curative resection and\/or local ablative therapy or systemic therapy in the Finnish Raxo-study","volume":"14","author":"Lehtom\u00e4ki K","year":"2022","unstructured":"Lehtom\u00e4ki K, Stedt HP, Osterlund E, et al.. Health-related quality of life in metastatic colorectal cancer patients treated with curative resection and\/or local ablative therapy or systemic therapy in the Finnish Raxo-study. Cancers (Basel). 2022, 14:1713. 10.3390\/cancers14071713","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2022.11.003","article-title":"Preliminary evaluation of PTV margins for online adaptive radiation therapy of the prostatic fossa","volume":"13","author":"Morgan HE","year":"2023","unstructured":"Morgan HE, Wang K, Yan Y, et al.. Preliminary evaluation of PTV margins for online adaptive radiation therapy of the prostatic fossa. Pract Radiat Oncol. 2023, 13:e345-53. 10.1016\/j.prro.2022.11.003","journal-title":"Pract Radiat Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2023.101405","article-title":"Intrafraction motion and margin assessment for ethos online adaptive radiotherapy treatments of the prostate and seminal vesicles","volume":"9","author":"Byrne M","year":"2024","unstructured":"Byrne M, Teh AY, Archibald-Heeren B, et al.. Intrafraction motion and margin assessment for ethos online adaptive radiotherapy treatments of the prostate and seminal vesicles. Adv Radiat Oncol. 2024, 9:101405. 10.1016\/j.adro.2023.101405","journal-title":"Adv Radiat Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-023-02394-2","article-title":"Evaluation of PTV margins with daily iterative online adaptive radiotherapy for postoperative treatment of endometrial and cervical cancer: a prospective single-arm phase 2 study","volume":"19","author":"Wang G","year":"2024","unstructured":"Wang G, Wang Z, Guo Y, et al.. Evaluation of PTV margins with daily iterative online adaptive radiotherapy for postoperative treatment of endometrial and cervical cancer: a prospective single-arm phase 2 study. Radiat Oncol. 2024, 19:2. 10.1186\/s13014-023-02394-2","journal-title":"Radiat Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tipsro.2024.100242","article-title":"The impact of an advanced practice radiation therapist contouring for a CBCT-based adaptive radiotherapy program","volume":"30","author":"Beckert R","year":"2024","unstructured":"Beckert R, Schiff JP, Morris E, Samson P, Kim H, Laugeman E. The impact of an advanced practice radiation therapist contouring for a CBCT-based adaptive radiotherapy program. Tech Innov Patient Support Radiat Oncol. 2024, 30:100242. 10.1016\/j.tipsro.2024.100242","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13961","article-title":"A roadmap for implementation of kV-CBCT online adaptive radiation therapy and initial first year experiences","volume":"24","author":"Stanley DN","year":"2023","unstructured":"Stanley DN, Harms J, Pogue JA, et al.. A roadmap for implementation of kV-CBCT online adaptive radiation therapy and initial first year experiences. J Appl Clin Med Phys. 2023, 24:e13961. 10.1002\/acm2.13961","journal-title":"J Appl Clin Med Phys"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.101034","article-title":"Online adaptive radiation therapy and opportunity cost","volume":"8","author":"McComas KN","year":"2023","unstructured":"McComas KN, Yock A, Darrow K, Shinohara ET. Online adaptive radiation therapy and opportunity cost. Adv Radiat Oncol. 2023, 8:101034. 10.1016\/j.adro.2022.101034","journal-title":"Adv Radiat Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280183-stereotactic-ablative-radiotherapy-for-oligometastatic-pericolonic-soft-tissue-metastases-using-daily-cone-beam-computed-tomography-guided-online-adaptive-radiotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T21:07:15Z","timestamp":1727039235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280183-stereotactic-ablative-radiotherapy-for-oligometastatic-pericolonic-soft-tissue-metastases-using-daily-cone-beam-computed-tomography-guided-online-adaptive-radiotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,22]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.69937","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,22]]}}}